AEMD:NSD-Aethlon Medical, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 5.86

Change

+0.26 (+4.64)%

Market Cap

USD 0.09B

Volume

2.91M

Avg Analyst Target

USD 8.33 (+42.21%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-22 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

+8.27 (+1.33%)

USD49.04B 107.52 74.42
PODD Insulet Corporation

-0.02 (-0.01%)

USD18.60B 2,137.64 156.34
ABMD Abiomed, Inc

+0.69 (+0.21%)

USD14.64B 65.35 53.94
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

+1.31 (+1.63%)

USD12.15B 60.70 30.02
TNDM Tandem Diabetes Care, Inc

+2.92 (+2.90%)

USD6.30B N/A N/A
SWAV ShockWave Medical, Inc

-2.55 (-1.45%)

USD5.88B N/A N/A
IART Integra LifeSciences Holdings ..

-0.99 (-1.45%)

USD5.76B 34.19 20.57
INMD InMode Ltd

-2.54 (-2.26%)

USD4.05B 47.01 39.86
LIVN LivaNova PLC

-0.44 (-0.53%)

USD4.04B 77.40 N/A

ETFs Containing AEMD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 137.25% 95% A 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 137.25% 95% A 97% A+
Trailing 12 Months  
Capital Gain 180.38% 85% B 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 180.38% 85% B 92% A-
Trailing 5 Years  
Capital Gain -6.39% 43% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.39% 43% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 44.33% 74% C 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.33% 74% C 83% B
Risk Return Profile  
Volatility (Standard Deviation) 165.30% 14% F 8% F
Risk Adjusted Return 26.82% 44% F 43% F
Market Capitalization 0.09B 25% F 17% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 1.96 66% D 89% B+
Price/Book Ratio 8.03 28% F 18% F
Price / Cash Flow Ratio -12.72 55% F 75% C
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -84.99% 35% F 21% F
Return on Invested Capital -83.76% 20% F 9% F
Return on Assets -46.84% 12% F 5% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.02 100% A+ 99% A+
Short Percent 2.06% 71% C- 61% D-
Beta 0.68 76% C 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector